Publication | Closed Access
Bortezomib for treatment of therapy-refractory anti-NMDA receptor encephalitis
192
Citations
9
References
2016
Year
This retrospective case series provides Class IV evidence that bortezomib reduces antibody titers and improves the clinical course of patients with severe anti-NMDAR encephalitis.
| Year | Citations | |
|---|---|---|
Page 1
Page 1